Rhinitis medicamentosa

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Rhinitis medicamentosa
Synonyms	Rebound nasal congestion
Pronounce	N/A
Specialty	N/A
Symptoms	Nasal congestion, nasal discharge, sneezing
Complications	Chronic rhinitis, sinusitis
Onset	After prolonged use of nasal decongestants
Duration	Persistent until treatment is stopped
Types	N/A
Causes	Overuse of topical decongestants
Risks	Prolonged use of nasal sprays
Diagnosis	Clinical evaluation
Differential diagnosis	Allergic rhinitis, non-allergic rhinitis
Prevention	Limiting use of nasal decongestants to 3-5 days
Treatment	Discontinuation of decongestants, nasal corticosteroids, saline nasal sprays
Medication	Intranasal corticosteroids, antihistamines
Prognosis	N/A
Frequency	Common in individuals using nasal decongestants
Deaths	N/A

Common nasal vasoconstrictor sprays that can lead to rhinitis medicamentosa.

Rhinitis medicamentosa is a condition characterized by nasal congestion that occurs as a result of the overuse of topical nasal decongestants. This condition is also known as "rebound congestion" and is a form of drug-induced rhinitis.

Pathophysiology

Rhinitis medicamentosa is primarily caused by the prolonged use of topical nasal decongestants, such as oxymetazoline, phenylephrine, and xylometazoline. These medications are sympathomimetic amines that act as vasoconstrictors, reducing blood flow to the nasal mucosa and thereby decreasing swelling and congestion. However, with continuous use beyond 3-5 days, the nasal mucosa becomes less responsive to the medication, leading to a cycle of dependency and worsening congestion when the medication is not used.

Symptoms

The primary symptom of rhinitis medicamentosa is persistent nasal congestion that does not improve with continued use of nasal decongestants. Patients may also experience: - Nasal obstruction - Difficulty breathing through the nose - Increased nasal discharge - Dryness or irritation of the nasal passages

Diagnosis

Diagnosis of rhinitis medicamentosa is typically based on the patient's history of nasal decongestant use and the presence of symptoms. A physical examination may reveal swollen nasal turbinates and erythematous mucosa. In some cases, nasal endoscopy may be performed to assess the extent of mucosal changes.

Treatment

The primary treatment for rhinitis medicamentosa is the cessation of the offending nasal decongestant. This can be challenging for patients due to the rebound congestion that occurs upon withdrawal. Management strategies include: - Gradual tapering of the decongestant - Switching to oral decongestants or antihistamines - Use of intranasal corticosteroids to reduce inflammation - Saline nasal sprays to maintain moisture and aid in mucosal recovery

Prevention

To prevent rhinitis medicamentosa, it is recommended to limit the use of topical nasal decongestants to no more than 3-5 consecutive days. Patients should be educated on the risks of overuse and encouraged to seek alternative treatments for chronic nasal congestion.

Also see

- Rhinitis - Nasal decongestant - Nasal spray - Rebound effect